Drug Discovery Technologies
Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the drug discovery technologies market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[190 Pages Report] The Drug Discovery Technologies Market size was estimated at USD 64.57 billion in 2023 and expected to reach USD 71.32 billion in 2024, at a CAGR 10.64% to reach USD 131.08 billion by 2030.

Drug discovery consists of new medications being discovered by using a vast array of technologies in the process. Drug discovery technologies are used to research and launch new drugs. The rising focus on healthcare has increased pharmaceutical drug consumption and created high demand for these medications worldwide. The prevalence of chronic diseases supplements this demand and therefore fuels the drug discovery technologies market potential. The rising incidences of diseases, pathogen resistance to old drugs, patent expiries, and fierce competition among drug manufacturers are the key factors driving the market's growth during the last couple of years. However, high costs, the long duration of the drug discovery process, and stringent regulatory mandates regarding drug development in various regions are restricting the market growth. Moreover, technological advancements, such as nanotechnology and RNA interference, are creating more efficient drug discovery platforms which fast-track the drug development cycle and enable drug manufacturers to develop effective drugs in a shorter period than conventional methods.

Regional Insights

The drug discovery technologies market in the Americas is highly evolving owing to the increasing need for advanced drugs and therapies to treat chronic and infectious disorders, supportive government initiatives for digitalizing drug discovery procedures, and ongoing advancements in drug discovery technologies. The investments by the Canadian government of around 59 million for the Canadian Critical Drug Initiative as part of an effort to boost drug research, commercialization, and manufacturing in the Alberta province and ongoing efforts by the United States to improve the regulatory science research activities have improved the utilization of drug discovery technologies in Americas. Moreover, the rising numbers of clinical trials, the presence of appropriate healthcare infrastructure, and supportive government approvals for healthcare drugs are expanding the scope of drug discovery technologies in the EMEA region. According to the European Medicines Agency (EMA), in the European Economic Area (EEA), approximately 4,000 clinical trials are authorized each year. In addition, the Asian government's focus on prioritizing AI in healthcare for drug discovery is expected to create growth opportunities for the drug discovery technologies market in the coming years.

Drug Discovery Technologies Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug Discovery Technologies Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growing use of small-molecular and biologics drugs to treat chronic and infectious disorders
    • Supportive government iniatives and investments for drug discovery and development
    • Rapid adoption of drug discovery technologies by CDMOs worldwide
  • Market Restraints
    • High initial setup cost for drug discovery and development
  • Market Opportunities
    • Ongoing technological advancements in drug discovery platforms
    • Increasing research and development expenditure for development of novel drug molecules
  • Market Challenges
    • Stringent regulatory environment and limited availability of skilled professionals
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Drug Discovery Technologies Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Drug Discovery Technologies Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Drug Discovery Technologies Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Drug Discovery Technologies Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Drug Discovery Technologies Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Drug Discovery Technologies Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Drug Discovery Technologies Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Drug Discovery Technologies Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Drug Discovery Technologies Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Drug Discovery Technologies Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

As a leading player in the drug discovery and development sector, we at Eurofins Advinus Private Limited faced significant challenges in staying ahead of market trends and understanding the evolving landscape of small-molecular and biologics drugs for chronic and infectious disorders. The Drug Discovery Technologies Market Research Report published by 360iResearch provided us with valuable insights and actionable strategies that were pivotal in overcoming these challenges. The report's comprehensive analysis highlighted emerging trends, key market players, and innovative technologies, enabling us to make informed decisions and stay competitive. For instance, the detailed segmentation and growth forecasts allowed us to identify new market opportunities and streamline our R&D efforts. We are extremely satisfied with the depth of information and the practical applications derived from the report, which have significantly impacted our operations positively.
Eurofins Advinus Private Limited
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Discovery Technologies Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Discovery Technologies Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Drug Development Technology player ArisGlobal Completes Acquisition of Amplexor Life Sciences.

    ArisGlobal's acquisition of Amplexor Life Sciences signals a major shift in the drug discovery technologies market. This merger brings together two industry players in enterprise software solutions that leverage automation, data-driven insights, and a deep understanding of regulatory compliance across the drug research lifecycle to deliver enhanced value to life sciences companies. With this move, ArisGlobal has expanded its global presence, giving clients access to a broader range of services and products. Combining deep domain knowledge with cutting-edge technologies provides customers with unprecedented end-to-end support for their drug discovery initiatives. With this new alliance, life sciences companies can now take advantage of innovative tools for clinical trial management, AI-powered decisions, greater visibility into patient data, and improved collaboration between internal and external partners. Ultimately, this means faster time to market with improved accuracy and quality in drug development. [Published On: 2023-04-20]

  • Luxna Announces Collaboration Agreement for Drug Discovery Research with Servier

    Luxna recently announced a collaboration agreement with Servier for conducting drug discovery research. This agreement reflects the industry's increased focus on utilizing innovative technologies and platforms to improve drug development processes. Luxna’s unique platform is backed by a large-scale data set of known compounds, enabling its partners to identify potential new leads and explore novel target spaces. The partnership will allow Servier to incorporate Luxna’s powerful technology into its drug discovery process and potentially expedite the development of new medicines. In light of this news, it can be seen that drug discovery technologies are becoming more advanced and efficient, allowing firms to gain an edge over their competitors in the market. [Published On: 2023-04-06]

  • Iktos Raises €15.5M (USD 16.34 million) to Expand AI Drug Discovery Technologies

    Iktos' recent investment of €15.5 Million (USD 16.34 million) to expand their AI drug discovery technologies is a positive sign for the future of the drug discovery technologies market. AI technologies provide faster and more accurate means for large-scale screening, which can lead to more efficient drug development and improved safety profiles. Additionally, AI-driven platforms could reduce the costs associated with drug discovery and development, making them attractive to researchers and pharma companies. The increased investment in Iktos reflects a larger movement towards the use of AI in drug discovery; this trend is likely to continue as technology advances and data sets become increasingly available. [Published On: 2023-03-09]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Discovery Technologies Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Before utilizing the Drug Discovery Technologies Market Research Report by 360iResearch, we faced significant challenges in navigating the rapidly evolving drug discovery landscape for CDMOs globally. The report provided us with invaluable insights and actionable strategies, highlighting key trends and technological advancements that are driving the market. By leveraging the findings, we were able to swiftly adopt new technologies, resulting in enhanced operational efficiency and a competitive edge. This comprehensive resource has been instrumental in guiding our strategic decisions and positioning our company for future growth. We are thoroughly satisfied with the positive impact it has had on our operations.
Parr Instrument Company
To learn more about this report, request a free PDF copy
Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Technologies Market, highlighting leading vendors and their innovative profiles. These include Eurofins Advinus Private Limited, Parr Instrument Company, Revolution Medicines, Inc., GE Healthcare Ltd., Bristol-Myers Squibb Company, Amgen Inc., AstraZeneca PLC, Abbott Laboratories, Inc., WuXi AppTec Co., Ltd., Sygnature Discovery Limited, Elucidata Corporation, Pfizer Inc., Luminex Corporation by DiaSorin Group, Hichrom Limited by VWR International, Applied Biosystems by Thermo FIsher Scientific, bioMérieux, Evotec SE, Merck & Co., Inc., Gilead Sciences, Inc., Bio-Rad Laboratories, Inc., Horiba, Ltd., Bayer Healthcare AG, Illumina, Inc., Sanofi, Agilent Technologies, Inc, Base Pair Biotechnologies by Aptamer Discovery Company, Covaris, LLC, Novartis AG, IQVIA Inc., Piramal Pharma Solutions, Curia Global, Inc., Randox Laboratories Ltd., F. Hoffmann-La Roche Ltd., and Syngene International Limited.

Drug Discovery Technologies Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Drug Discovery Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Bioanalytical Instruments
    • Biochips
    • Bioinformatics
    • Combinatorial Chemistry
    • Genomics
    • High Throughput Screening
    • Nanotechnology
    • Pharmacogenomics
    • RNA interference
  • Drug Type
    • Biologic Drugs
    • Small-molecule Drugs
  • End User
    • Biopharmaceutical Companies
    • Biotech Companies
    • Pharmaceutical Companies
    • Research Institutes

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Before utilizing the Drug Discovery Technologies Market Research Report published by 360iResearch, we at Revolution Medicines faced significant challenges in strategically planning our R&D investments. The report provided us with valuable insights and actionable strategies specifically tailored to increasing research and development expenditure for the development of novel drug molecules. For instance, it identified key trends and emerging technologies that aligned perfectly with our research goals, allowing us to optimize our resource allocation effectively. As a result, we saw accelerated progress in our drug discovery projects and gained a competitive edge in the market. The comprehensive analysis and detailed recommendations positively impacted our decision-making processes and overall operations. We couldn’t be more satisfied with the report's impact on our organization's success.
Revolution Medicines, Inc.
To learn more about this report, request a free PDF copy
This research report offers invaluable insights into various crucial aspects of the Drug Discovery Technologies Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Drug Discovery Technologies Market, by Technology
  7. Drug Discovery Technologies Market, by Drug Type
  8. Drug Discovery Technologies Market, by End User
  9. Americas Drug Discovery Technologies Market
  10. Asia-Pacific Drug Discovery Technologies Market
  11. Europe, Middle East & Africa Drug Discovery Technologies Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 298]
  16. List of Companies Mentioned [Total: 34]
Advancements in Drug Discovery Technologies: Revolutionizing the Future of Medicine
June 27, 2023
BLOG
Advancements in Drug Discovery Technologies: Revolutionizing the Future of Medicine
Drug discovery is a crucial process that involves identifying and developing new and effective medications to address various diseases and medical conditions. In recent years, scientific advancements have significantly impacted drug discovery technologies, making it possible for researchers and pharmaceutical companies to develop drugs more efficiently and effectively. These technological advancements have proven to be beneficial to both the scientific community and patients, and we can expect further transformative developments in the future.

The first significant breakthrough in drug discovery technologies came with the introduction of in-silico drug screening systems. In-silico drug screening systems integrate various software and computational tools to simulate and analyze drug-target interactions. They enable scientists to conduct virtual experiments to develop drugs without the need for laboratory testing. This technology is hugely advantageous as it eliminates many of the logistical and financial barriers associated with traditional drug discovery methods.

The second major technological development in drug discovery technologies is protein engineering. The use of protein engineering involves creating proteins with specific functions to address the molecular-level challenges associated with drug design. For instance, scientists can use protein engineering to modify existing enzymes or create new enzymes with the desired properties required for drug development. This technology is vital in developing new drug formulations and dosage forms.

Another crucial technology for drug discovery is high-throughput screening (HTS). HTS allows researchers to test thousands of drug compounds at once, making the drug discovery process more efficient and cost-effective. This technology has been particularly useful in identifying potential therapies for complex diseases such as cancer, where there are often many different subtypes of the disease.

Artificial intelligence (AI) is another game-changing technology in drug discovery. AI can speed up and improve the drug discovery process by analyzing vast amounts of data in seconds or minutes, which may take scientists several years to accomplish. AI has enabled researchers to identify new drug candidates that were previously missed by traditional methods, resulting in the development of new treatments for various medical conditions.

Drug discovery aims to develop new treatments and therapies to improve human health, and advancements in technology will undoubtedly continue to drive innovation in this field. Technological advancements such as AI, protein engineering, high-throughput screening, and in-silico drug screening systems have changed how we approach drug discovery, making it more efficient, cost-effective, and targeted. As scientific technologies continue to evolve, we can expect further transformative developments in drug discovery. These developments play a crucial role in revolutionizing the future of medicine, leading to the development of new treatments and therapies that aids in improving the quality of life for millions of individuals worldwide.

Frequently Asked Questions
  1. How big is the Drug Discovery Technologies Market?
    Ans. The Global Drug Discovery Technologies Market size was estimated at USD 64.57 billion in 2023 and expected to reach USD 71.32 billion in 2024.
  2. What is the Drug Discovery Technologies Market growth?
    Ans. The Global Drug Discovery Technologies Market to grow USD 131.08 billion by 2030, at a CAGR of 10.64%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.